Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Calibra Medical gets $9.3mm in Series C

15 Mar 2010

Executive Summary

Calibra Medical, which recently obtained regulatory approval for its Finesse insulin delivery device, has raised $9.3mm through the sale of equity and other rights in its Series C financing. Returning shareholders Canaan Partners, Frazier Healthcare Ventures, Intersouth Partners, and Three Arch Partners participated along with two other investors. According to a Form D filing, the round could generate a total of $32.3mm but the company says some of that will come from the conversion of warrants.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By